Overview
Updated 14 Jul 2026
David Callanan, MD, is Senior Vice President & Chief Medical Officer, Aviceda Therapeutics. The public record shows 119 publications with 5,919 citations (h-index 39), centered on Macular Degeneration (AMD), Dry Eye / Uveitis, Glaucoma. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 5 companies, 1 NIH-funded awards (1985–1986).
- Most recent indexed publication: 2026 · Journal of vitreoretinal diseases
- Top research focus: Macular Degeneration (AMD)
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Sponsor: Aviceda Therapeutics, Inc.
InvestigatorPhase 2TerminatedNCT06181227 - A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Sponsor: Aviceda Therapeutics, Inc.
InvestigatorPhase 2Active, not recruitingNCT05839041 - A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Sponsor: Johns Hopkins University
InvestigatorPhase 2TerminatedNCT01565148
Industry payments
Updated 14 Jul 2026
5 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- EyePoint Pharmaceuticals US, Inc.Program year20223 payments
- Genentech USA, Inc.Program year20221 payment
- Alimera Sciences, Inc.Program year20212 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Multifocal Electroretinography Outcomes Following AVD-104 Treatment for Geographic Atrophy.
Journal of vitreoretinal diseases
2026 - Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.
Clinical ophthalmology (Auckland, N.Z.)
2023
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
University of Iowa College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗ - Residency
Internal Medicine and Ophthalmology, Parkland Memorial Hospital / UT Southwestern
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗
- Board Certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership rolesjournal and society appointments
- Elected Member
The Macula Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗ - Elected Member
Club Jules Gonin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗ - Member
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texasretina.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗
Secondary affiliationsappointments beyond the home institution
- Clinical Professor
Department of Ophthalmology, UT Southwestern Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗ - Board of Directors
Retina Foundation of the Southwest
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →avicedarx.com ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →businesswire.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →modernretina.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/david-callanan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/david-callanan-82512aa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
asrs.org/find-a-specialist/profile/140/David-Callanan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Mentions by otherswhere others cite or feature them
- Other
businesswire.com/news/home/20210111005213/en/Aviceda-Therapeutics-Announces-Formation-of-Executive-Team
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗ - Other
texasretina.com/our-physicians/david-callanan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasretina.com ↗ - LinkedIn
LinkedIn profile listing him as CMO at Aviceda Therapeutics (auth-walled; title corroborated via SERP snippet)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.